DELFI Diagnostics is a cancer detection company that utilizes artificial intelligence and whole genome fragmentation analysis to develop blood-based cancer screening tests, such as for lung cancer.
Subscribe to see Delfi Diagnostics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Delfi Diagnostics, Inc. is a diagnostics company headquartered in United States. It has raised at least $365.9M across the 5 funding rounds on record. Its most recent funding round raised $34.3M in December 2025. Xcout tracks 36 named people at Delfi Diagnostics, Inc., including Susan Tousi (Chief Executive Officer). Xcout recorded 14 job postings from Delfi Diagnostics, Inc. in the last 90 days, naming tools such as Palo Alto Networks.
30 more named people on record for Delfi Diagnostics, Inc., with roles, board committees and tenure — see the full roster →
At least $365.9M raised across the 5 rounds on record. The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $34.3M | — | |
| Series B | $225M | 13 named | |
| — | $101.1M | 13 named | |
| SEC Form D filing | $5.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Xcout recorded 14 job postings from Delfi Diagnostics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Delfi Diagnostics, Inc.'s hiring signals →
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.